Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Devaraj Ezhilarasan. (2023) Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms. Drug Metabolism Reviews 55:3, pages 239-253.
Read now
Read now
Xihui Zhang, Tianyan Jiang, Dandan Chen, Qi Wang & Leshuai W. Zhang. (2020) Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation. Critical Reviews in Toxicology 50:4, pages 279-309.
Read now
Read now
Articles from other publishers (38)
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt & Alastair D. Burt. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
330
401
.
KM Kainat, Mohammad Imran Ansari, Nuzhat Bano, Pankaj Ramji Jagdale, Anjaneya Ayanur, Mahadeo Kumar & Pradeep Kumar Sharma. (2023) Rifampicin-induced ER stress and excessive cytoplasmic vacuolization instigate hepatotoxicity via alternate programmed cell death paraptosis in vitro and in vivo. Life Sciences 333, pages 122164.
Crossref
Crossref
Karissa E. Cottier, Devika Bhalerao, Candice Lewis, Jeannemarie Gaffney & Scott A. Heyward. (2023) Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening. Scientific Reports 13:1.
Crossref
Crossref
Marta Alonso-Peña, Maria Del Barrio, Ana Peleteiro-Vigil, Carolina Jimenez-Gonzalez, Alvaro Santos-Laso, Maria Teresa Arias-Loste, Paula Iruzubieta & Javier Crespo. (2023) Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key. International Journal of Molecular Sciences 24:13, pages 10718.
Crossref
Crossref
Juan Esparza, Utsav Shrestha, David E. Kleiner, James M. Crawford, Jason Vanatta, Sanjaya Satapathy & Aaryani Tipirneni-Sajja. (2023) Automated Segmentation and Morphological Characterization of Hepatic Steatosis and Correlation with Histopathology. Journal of Clinical and Experimental Hepatology 13:3, pages 468-478.
Crossref
Crossref
Dominique Larrey, Laura D'Erasmo, Sallyann O'Brien & Marcello Arca. (2022) Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. Liver International 43:2, pages 413-423.
Crossref
Crossref
Zhaojuan Guo, Yuanyuan Shi, Bingqian Jiang, Xiyi Peng, Lin Zhang, Can Tu & Ting Wang. (2023) Psoraleae Fructus Ethanol Extract Induced Hepatotoxicity via Impaired Lipid Metabolism Caused by Disruption of Fatty Acid β-Oxidation. Oxidative Medicine and Cellular Longevity 2023, pages 1-17.
Crossref
Crossref
Liana Gheorghe & Speranta Iacob. 2023. Essentials of Non-Alcoholic Fatty Liver Disease. Essentials of Non-Alcoholic Fatty Liver Disease
133
147
.
Giovanni Guarneri, Diego Palumbo, Nicolò Pecorelli, Francesco Prato, Chiara Gritti, Raffaele Cerchione, Domenico Tamburrino, Stefano Partelli, Stefano Crippa, Michele Reni, Francesco De Cobelli & Massimo Falconi. (2022) The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer. Annals of Surgical Oncology 29:11, pages 7063-7073.
Crossref
Crossref
Xiaoxia Wang, Yuchuan Tan, Daihong Liu, Hesong Shen, Yongchun Deng, Yong Tan, Lei Wang, Yipeng Zhang, Xin Ma, Xiaohua Zeng & Jiuquan Zhang. (2022) Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy. European Radiology 32:7, pages 4898-4908.
Crossref
Crossref
Thomas Kralj, Raju Khatri, Kenneth R. Brouwer, Kim L. R. Brouwer & Darren J. Creek. (2022)
Lipidomics profiles in hepatocytes from nonalcoholic steatohepatitis patients differ markedly from
in vitro
‐induced steatotic hepatocytes
. FEBS Letters 596:11, pages 1445-1452.
Crossref
Crossref
Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, Joery De Kock, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke & Joost Boeckmans. (2022) From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights. Biomedicines 10:1, pages 161.
Crossref
Crossref
Michael Torbenson, Sanjay Kakar & Kay Washington. 2022. Non-Neoplastic Diseases of the Liver. Non-Neoplastic Diseases of the Liver
237
263
.
R. Paternostro, W. Sieghart, M. Trauner & M. Pinter. (2021) Cancer and hepatic steatosis. ESMO Open 6:4, pages 100185.
Crossref
Crossref
Li-Guang Fang & Quan Zhou. (2021) Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview. World Journal of Clinical Cases 9:19, pages 4969-4979.
Crossref
Crossref
Utsav Shrestha, Marie Merwe, Nirman Kumar, Eddie Jacobs, Sanjaya K. Satapathy, Cara Morin & Aaryani Tipirneni‐Sajja. (2021) Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivity. NMR in Biomedicine 34:6.
Crossref
Crossref
Mauro Cataldi, Vincenzo Citro, Chiara Resnati, Federica Manco & Giovanni Tarantino. (2021) New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants. Advances in Therapy 38:5, pages 2094-2113.
Crossref
Crossref
Qiaoling Wang, Ang Huang, Jia-Bo Wang & Zhengsheng Zou. (2021) Chronic Drug-Induced Liver Injury: Updates and Future Challenges. Frontiers in Pharmacology 12.
Crossref
Crossref
Jaehwan Ahn, Jun-Ho Ahn, Seokjoo Yoon, Mi-Young Son, Sungbo Cho & Jung-Hwa Oh. (2021) Quantification of non-alcoholic fatty liver disease progression in 3D liver microtissues using impedance spectroscopy. Biomaterials 268, pages 120599.
Crossref
Crossref
Venkat R. Pannala, Shanea K. Estes, Mohsin Rahim, Irina Trenary, Tracy P. O’Brien, Chiyo Shiota, Richard L. Printz, Jaques Reifman, Masakazu Shiota, Jamey D. Young & Anders Wallqvist. (2020) Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats. International Journal of Molecular Sciences 21:21, pages 8250.
Crossref
Crossref
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, Aida Ortega-Alonso, M. Isabel Lucena & Raúl J. Andrade. (2020) Drug induced liver injury: an update. Archives of Toxicology 94:10, pages 3381-3407.
Crossref
Crossref
A. P. Pereverzev & O. D. Ostroumova. (2020) Drug-Induced Fatty Liver Disease. Safety and Risk of Pharmacotherapy 8:2, pages 66-76.
Crossref
Crossref
Andre Castro Lyra, Lorena Mascarenhas Carneiro de Almeida, Yukari Figueroa Mise & Lourianne Nascimento Cavalcante. (2020) Epidemiological profile of alcoholic liver disease hospital admissions in a Latin American country over a 10-year period. World Journal of Hepatology 12:5, pages 230-238.
Crossref
Crossref
Andre Castro Lyra, Lorena Mascarenhas Carneiro de Almeida, Yukari Figueroa Mise & Lourianne Nascimento Cavalcante. (2020) Epidemiological profile of alcoholic liver disease hospital admissions in a Latin American country over a 10-year period. World Journal of Hepatology 12:5, pages 220-228.
Crossref
Crossref
Shao-jie Huang, Fei Mu, Fei Li, Wen-jun Wang, Wei Zhang, Lu Lei, Yang Ma & Jing-wen Wang. (2020) Systematic Elucidation of the Potential Mechanism of Erzhi Pill against Drug-Induced Liver Injury via Network Pharmacology Approach. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-15.
Crossref
Crossref
Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke & Robim M. Rodrigues. (2019) Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. Cells 9:1, pages 37.
Crossref
Crossref
Bernard Fromenty. (2019) Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis. Liver Research 3:3-4, pages 157-169.
Crossref
Crossref
Lauren Pavlik, Arie Regev, Paul A. Ardayfio & Naga P. Chalasani. (2019) Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Drug Safety 42:6, pages 701-711.
Crossref
Crossref
Gil Ben‐Yakov, Hawwa Alao, John P. Haydek, Nancy Fryzek, Min Ho Cho, Mehdi Hemmati, Vikram Samala, Margaret Shovlin, Kieron Dunleavy, Wyndham Wilson, Elizabeth C. Jones & Yaron Rotman. (2018) Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma. Hepatology Communications 3:2, pages 220-226.
Crossref
Crossref
Miyako Kishimoto, Masayuki Adachi, Koichi Takahashi & Kazushige Washizaki. (2019) Clonazepam-induced liver dysfunction, severe hyperlipidaemia, and hyperglycaemic crisis: A case report. SAGE Open Medical Case Reports 7, pages 2050313X1984297.
Crossref
Crossref
Ajit Dash & William R. Proctor. 2019. Microfluidic Cell Culture Systems. Microfluidic Cell Culture Systems
159
186
.
Karima Begriche, Julie Massart & Bernard Fromenty. 2019. Mitochondria in Obesity and Type 2 Diabetes. Mitochondria in Obesity and Type 2 Diabetes
347
364
.
Yuya Urano, Shingo Oda, Koichi Tsuneyama & Tsuyoshi Yokoi. (2018) Comparative hepatic transcriptome analyses revealed possible pathogenic mechanisms of fasiglifam (TAK-875)-induced acute liver injury in mice. Chemico-Biological Interactions 296, pages 185-197.
Crossref
Crossref
Matthias Cuykx, Robim M. Rodrigues, Kris Laukens, Tamara Vanhaecke & Adrian Covaci. (2018) In vitro assessment of hepatotoxicity by metabolomics: a review. Archives of Toxicology 92:10, pages 3007-3029.
Crossref
Crossref
Aida Ortega-Alonso & Raúl J Andrade. (2018) Chronic liver injury induced by drugs and toxins. Journal of Digestive Diseases 19:9, pages 514-521.
Crossref
Crossref
Raj Vuppalanchi & Marwan Ghabril. (2018) Uncommon Presentations of Idiosyncratic Drug-Induced Liver Injury. Current Hepatology Reports 17:3, pages 254-259.
Crossref
Crossref
Francesco MasiaIestyn PopePeter WatsonWolfgang LangbeinPaola Borri. (2018) Bessel-Beam Hyperspectral CARS Microscopy with Sparse Sampling: Enabling High-Content High-Throughput Label-Free Quantitative Chemical Imaging. Analytical Chemistry 90:6, pages 3775-3785.
Crossref
Crossref
Cezary Chojnacki, Aleksandra Błońska & Jan Chojnacki. (2017) The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment. BioMed Research International 2017, pages 1-7.
Crossref
Crossref